News

27 April 2016; Company Announcement FMOLHS April 2016 - Acrobat pdf 163k Key Points Franciscan Missionaries of Our Lady Health System (FMOLHS) to use Pro Medicus’ Visage 7 technology for primary diagnosis and enterprise distribution of medical images Seven-year deal with base value to PME of A$7M Transaction-based model with potential upside Second deal as part of the ROi master purchasing agreement Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned US subsidiary Visage Imaging, Inc has signed an A$7 million, 7-year contract with the Franciscan Missionaries of Our Lady Health System (“FMOLHS”), the largest health system in the U.S. state of Louisiana. The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented at FMOLHS’s five acute care and specialty hospitals. Once fully implemented, Visage 7 will be a key component of FMOLHS’s enterprise viewing platform and will be used for primary diagnoses, enterprise distribution and access to radiology images by over 2,000 physicians via the system’s new electronic health record (EHR). FMOLHS is also a shareholder of ROi, a leading US health care supply-chain organization with this the second deal completed under the Visage/ROi agreement announced in April of this year. Planning for the project is scheduled to begin in the first quarter of FY2017, with the first phase of the implementation to commence in the 2nd half of FY2017 to coincide with the rollout of FMOLHS’s EHR. It is estimated the project will take 12 months to complete. The FMOHLS sale builds on the four large enterprise system deals Pro Medicus has won in the previous 12 months. These include the University of Florida Health in April 2015, Allegheny Health Network in September 2015, a

20 April 2016; PME Appoints Anthony Glenning as Director - Acrobat pdf 184k Leading health imaging company Pro Medicus Limited [ASX: PME] today announced the appointment of Mr Anthony Glenning as a Non- Executive Director, effective 1 May 2016. At last year’s AGM the Chairman indicated that the Board intended appointing another Non-Executive Director with complementary skills. With the assistance of an Executive Search firm the Board conducted an extensive search to identify suitable candidates. Today’s announcement is the culmination of that process. Mr Glenning has considerable experience in software development and has spent approximately 14 years living and working in Silicon Valley in California USA. He has a background in engineering and holds a Master’s degree in Electrical Engineering from Stanford University, along with Bachelors’ degrees in Computer Science and Electrical Engineering from the University of Melbourne. Mr Glenning was the founder and CEO of Tonic Systems, a company that developed software for creating and managing online presentations, which was sold to Google in 2007. The software was integrated into Google’s online corporate software – Google Docs, with Anthony working for Google at the Googleplex headquarters in the two years following the acquisition. Mr Glenning was also a founding non- executive director of Cameron Systems, a company providing software solutions to financial businesses until it was acquired by Orc Software in 2006. Mr Glenning joined investment firm Starfish Ventures in 2010 where he is currently an Investment Director and sits on the boards of a number of Starfish portfolio companies. The Board welcomes Anthony to the company and looks forward to working with him.

4 April 2016  |   PME CEO on Mercy Contract - Acrobat pdf 238k Open Briefing interviewed Pro Medicus CEO, Dr Sam Hupert, discussing the latest contract with Mercy.        

4 April 2016; Company Announcement Pro Medicus Signs Mercy - Acrobat pdf 169k Key Points Mercy Health System to use Pro Medicus’ Visage 7 technology for primary diagnosis and distribution of medical images Seven-year deal with base value to PME in excess of A$21M Mercy has 46 acute care and specialty hospitals spanning four US states Transaction-based model with potential upside First deal as part of the ROi Master purchasing agreement Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned US subsidiary Visage Imaging, Inc has signed an A$21 million, 7-year contract with Mercy Health System (‘Mercy’), the seventh largest Catholic health care system in the USA. The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented across Mercy’s 46 acute care and specialty hospitals, supporting more than 2,000 physicians and 40,000 employees across the mid-west states of Missouri, Arkansas, Oklahoma and Kansas. Once fully implemented, Visage 7 will be a key component of Mercy’s enterprise viewing platform and will be used for primary diagnoses, clinical distribution and access to radiology images via Mercy’s electronic health record (EHR). Mercy is also the founder and major shareholder of ROi, a leading US health care supply-chain organization. As part of this deal Visage Imaging has entered into a master purchasing agreement with ROi. The deal with Mercy will be the first completed under this new ROi agreement. This paves the way for all ROi members to benefit from this group-wide purchasing agreement. Planning for the project is scheduled to begin in the last quarter of FY2016, with the first phase of the implementation to commence in the first quarter of FY2017. It is estimated the project will take between

15 March 2016 Dr Sam Hupert, CEO and Co-Founder, Pro Medicus, was one of the invited speakers at the 2016 ASX Spotlight Series New York. The ASX Spotlight Series is a targeted international investor conference, providing investors an opportunity to hear from senior executives from ASX-listed companies. In the below video interview, Dr Hupert provides a Pro Medicus overview, while also discussing market potential, competitive forces, financial performance and growth opportunities.      

19 February 2016  |   CEO on H1 Results - Acrobat pdf 493k   Open Briefing interviewed Pro Medicus CEO, Dr Sam Hupert, discussing the latest PME Interim Results.        

19 February 2016  |  Company Announcement Pro Medicus Limited 2016 Interim Results - Acrobat pdf 178k Key Points: After-tax profit of $2.94 million – up 82.9% Revenue of $14.28 million – up 65.3% Underlying profit from operations $2.82 million – up 188.5% Year-end cash reserves increased to $16.19 million Increased interim dividend of 1.5c per share (unfranked) Continuing strong inroads into North American market, including $11 million contract with Allegheny Health Network in Pittsburgh area Large contract signed in Europe Successfully completed implementation of 3 previously announced contracts Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a first half after-tax profit of $2.94 million for the six months to 31 December 2015 – an increase of $1.33 million (82.9%) on the previous corresponding period. Revenue for the six months was $14.28 million – a 65.3% increase on the previous corresponding period. Underlying profit from operations was $2.82 million compared to $0.98 million for the previous corresponding period – an increase of 188.5%. The company's cash reserves were $16.19 million at the end of the period, an increase of $3.26 million. The company remains debt-free and announced an increased interim dividend of 1.5c per share (unfranked). During the period the company made several key announcements – including a $11 million contract with the Allegheny Health Network, a large health system in the Pittsburgh area, and a $3 million deal with a large hospital network in Germany. These announcements further underlined Pro Medicus’ leading position in imaging technology and its gathering acceptance in international health markets. Dr Sam Hupert, Pro Medicus Chief Executive Officer, said the increase in revenue during the period was largely a result of transactional fees from the implemented contracts beginning to take

16 November 2015; Company Announcement Pro Medicus Signs Large German Hospital - Acrobat pdf 131k Key Points Large German government hospital to use Visage 7 technology throughout its’ diagnostic imaging facilities Cross-regional diagnostic image access with other key hospitals across Germany Five-year capital deal, with base value to PME of A$3 million Deconstructed PACS® gaining momentum in Europe Expands Visage footprint in key German hospital market Leading health imaging company, Pro Medicus Limited [ASX: PME] today announced its’ wholly owned European subsidiary, Visage Imaging GmbH, has signed a A$3 million five-year contract with one of the largest government run hospitals in Germany. As part of the deal, the hospital will implement Visage 7 as the central component of a Deconstructed PACS® strategy, integrating it to the hospitals’ recently selected workflow solution, and several existing DICOM archives. A testament to the flexibility of Visage 7, most of the diagnostic workstations will be installed on Apple Mac computers running OS X. Visage 7 “satellite” servers will also be implemented at three other government sites in northern and southern Germany to facilitate a new enhanced level of image sharing with these sites for cross-regional diagnostic imaging access. “Given the significant pressures on modern Radiology, we’re looking to Visage to provide a step-change in our historical capabilities,” said the department’s chief radiologist. “Visage’s speed and regional architecture will enable our physicians to have rapid access to images, from any of our hospitals, or wherever required to care for our soldiers and civilian patients. Visage also represents a fundamental change in how a system is configured. By adopting a modular strategy we will be able to seamlessly scale over time, while staying technologically ahead of our ever-growing volume of imaging data”.

5 October 2015 The Business's Ticky Fullerton interviewed Dr Sam Hupert, CEO and Founder of Pro Medicus, about "making waves and locking in contracts in the US with its Visage medical imaging technology."  Some additional key quotes from the interview include the following: "There's been a fundamental change in the way this technology is being purchased, and we're very much in that sweet spot…" "We can visualize massive data sets… on standard Internet… in 2-to-3 seconds" "We believe we're just scratching the surface in that market [the U.S.]." "A number of forces in the market have pushed the large health institutions to look at alternatives, and those forces are the ability to tie everything into one record — not just radiology — and clearly the size of the data sets the new radiology equipment is creating, and that favors our technology." "Their technology [legacy vendors] is not as well suited to the new paradigm as ours." Click on the video for the complete interview.